ATLANTA, Jan. 29, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter 2025 financial results ...
Operator: Good afternoon, and welcome to the Sangamo Therapeutics Second Quarter 2024 Teleconference Call. Please be advised that today’s conference is being recorded. I would now like to turn the ...
Operator: Good afternoon, and welcome to the Sangamo Therapeutics Second Quarter 2025 Teleconference Call. Please be advised that today’s conference is being recorded. I would now like to turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results